Access to advanced genomics technologies for cancer research
Official title: Genomics Shared Resource
Funded at University of Rochester · NIH-11014540 · Data updated 2026-11-12
This study is all about using advanced technology to look closely at the genes involved in cancer, helping researchers understand how cancer works better and find new ways to treat it.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $130,614 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014540 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who are interested in understanding the genetic factors of their disease.
✕Less likely to help
Patients with non-cancerous conditions or those not interested in genomic analysis may not receive benefit from this research.
What this research studies
The Genomics Shared Resource (GSR) at the Wilmot Cancer Institute provides researchers with access to cutting-edge genomics technologies to study cancer at the genetic level. This resource offers a variety of services, including DNA sequencing, single-cell genomics, and bioinformatics support, enabling comprehensive analysis of gene structure and function. By collaborating with experts in biostatistics and bioinformatics, the GSR ensures that researchers can effectively interpret complex genomic data. This initiative aims to enhance our understanding of cancer biology and improve therapeutic strategies.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by uncovering critical genetic insights.
How similar studies have gone: Previous research utilizing advanced genomics technologies has shown significant success in enhancing cancer treatment strategies.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Ashton, John — University of Rochester
- Study coordinator: Ashton, John
Related research
Other NIH-funded projects on the same topics.
-
Rapid automated breast lump diagnosis without a radiologist or sonographer
A new AI-powered ultrasound tool helps determine if a palpable breast lump is likely benign or malignant, using a simplified technique that can be used by people with minimal ultrasound training.
-
ML-ROVER: Reducing Unneeded Lab Tests in Kids with AI
Aims to use machine learning to cut unnecessary blood tests in children in intensive care, helping avoid anemia and improve care quality.
-
Aggressive fever-reducing therapy to protect the brains of children with CNS malaria
A study planned for children with CNS malaria will test whether aggressive fever-reducing treatment can lower death and brain-related problems.
-
Aggressive fever-reducing therapy to protect brains in children with CNS malaria
A plan to test whether giving strong fever-reducing medications to children with central nervous system malaria can lower death and brain injury.
-
Aggressive fever-fighting treatment to protect the brain in kids with CNS malaria
A plan to test whether giving strong fever-reducing treatment alongside standard care can lower death and brain injury in children with CNS malaria.
-
Aggressive fever-reducing treatment to protect brains in kids with CNS malaria
A plan to test whether giving strong fever-reducing medicine alongside standard malaria treatment can lower deaths and brain injuries in children with CNS malaria.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.